Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting ...Middle East

NORWOOD, Mass., March 14, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an abstract highlighting pre-clinical data for CRB-601, its avβ8 blocking antibody, has been accepted for...

Hence then, the article about corbus pharmaceuticals data on crb 601 avb8 blocking antibody accepted for presentation at the america association for cancer research annual meeting was published today ( Tuesday 14/03/2023 - 11:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting )

Also on site :

• Lisa Kudrow Gets Brutally Honest About ‘Friends’ Fame
• 2000s Heavy Metal Rocker Makes $1.5 Million Move Before 2026 Tour
• Iran strikes fully loaded Kuwaiti oil tanker at Dubai port; spill risk flagged